India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
CDSCO to fast-track trials and approval for COVID19 vaccine
Deal for 100 million doses with additional 100 million through 2023
Innovative solutions and a deep understanding of the market makes this a unique combination
It is part of the company’s pain/analgesics portfolio of OTC products
Robust demand for the product across the Middle East, Africa and Latin America
The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales
This deal makes Meddo, one of the largest health-tech players in India
The govt has rolled out three schemes for promoting the manufacture of API
Subscribe To Our Newsletter & Stay Updated
